pcsk9 inhibitors within the targeted treatment approach to hypercholesterolemia 4/26/16
Published 7 years ago • 2K plays • Length 1:03:46Download video MP4
Download video MP3
Similar videos
-
1:01
patient access to pcsk9 inhibitors
-
53:13
diagnosing and treating hyperlipidemia: recent evidence and the role of pcsk9-targeted therapies
-
52:04
a real world approach to ldl cholesterol using pcsk9 inhibitors, october 5 2018
-
33:45
leveraging pcsk9-targeting therapies in hyperlipidemia management to reduce cardiovascular risks
-
3:41
cost-effectiveness of pcsk9 inhibitors for heterozygous fh or ascvd
-
5:41
what is pcsk9 and how pcsk9 inhibitors work? (mechanism of action)
-
7:51
efficacy and safety of pcsk9 inhibitors
-
5:18
lipid management utilizing pcsk9 inhibitors
-
6:02
pcsk9 inhibitors and cv risk
-
1:29
pcsk9 inhibitors show benefits with challenges to overcome
-
17:08
lipids series-pcs k9 inhibitors
-
1:00:28
breaking down the barriers to pcsk9 inhibitor use in clinically appropriate patients
-
9:13
clinical experience with pcsk9 inhibitors
-
11:56
emergence of pcsk9 inhibitors
-
9:05
the oddessy of pcsk9 inhibitors: what might it mean for guidelines?
-
1:20
the role of pcsk9 inhibitors for patients with hyperlipidemia
-
0:32
managing patients on pcsk9 inhibitors
-
23:18
professor kausik ray - pcsk9 inhibition – have we reached the limits of lipid lowering and outcome?
-
1:32
the role of pcsk9 inhibitors for patients with hyperlipidemia